Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy (original) (raw)
Parving H-H, Smidt U, Friisberg B, Bonnevie-Nielsen V, Andersen AR (1981) A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: 457–461 ArticleCASPubMed Google Scholar
Borch-Johnson K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596 Google Scholar
Kostner GM, Karadi I (1988) Lipoprotein alterations in diabetes mellitus. Diabetologia 31: 717–722 ArticleCASPubMed Google Scholar
Moorhead JF, El-Nahas M, Chan MK, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 11: 1310–1311 Google Scholar
Mulec H, Johnson S-AA, Björck S (1990) Relation between serum cholesterol and diabetic nephropathy. Lancet 335: 1537–1538 ArticleCASPubMed Google Scholar
Diamond JR, Karnovsky MJ (1987) Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 32: 671–677 CASPubMed Google Scholar
Kasiske BI, O'Donnell M, Clearly MP, Keane WF (1989) Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats. Kidney Int 35: 40–47 CASPubMed Google Scholar
Rabelink AJ, Hene RJ, Erkelens DW, Joles JA, Koomans HA (1990) Partial remission of nephrotic syndrome in patients on long-term simvastatin. Lancet 335: 1045–1046 ArticleCASPubMed Google Scholar
Parving H-H, Andersen AR, Smidt UM, Svendsen PA (1983) Early aggressive antihypertensive treatment reduces the rate of decline in diabetic nephropathy. Lancet 1: 1175–1179 CASPubMed Google Scholar
Kattermann R, Joworek D, Möller G (1984) Multicenter study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem 22: 245–251 CASPubMed Google Scholar
Friedewald WT, Levy RI, Frederikson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499–502 CASPubMed Google Scholar
Andersen I, Hannibal S (1983) Analytical and economical optimization of a glucose method with immobilized enzymes. J Automatic Chemistry 4: 188–192 Google Scholar
Goldstein DE, Peth SB, England JD, Randall LH, DaCosta J (1980) Effects of acute changes in blood glucose on HbA1c. Diabetes 29: 623–628 CASPubMed Google Scholar
Bröchner-Mogensen J (1972) A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30: 271–274 Google Scholar
Miles DW, Mogensen CE, Gundersen HJG (1970) Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 26: 5–11 CASPubMed Google Scholar
Maroni BJ, Steinman TI, Mitch WE (1985) A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27: 58–65 CASPubMed Google Scholar
Isaksson B (1980) Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 33: 4–5 CASPubMed Google Scholar
Carlsen J, Køber L, Hansen A-D, Sindling A, Andersen P (1988) Electronic measurement of blood pressure. Technical and clinical assessment of medical UA 751. Ugeskr Laeger 150: 1280–1282 CASPubMed Google Scholar
Kasiske BI, O'Donnell MP, Keane WF (1987) The obese Zucker rat model of glomerular injury in Type 1 (insulin-dependent) diabetes. J Diab Compl 1: 26–29 CAS Google Scholar
Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF (1988) Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectorny model of chronic renal failure. Circ Res 62: 367–374 CASPubMed Google Scholar
Kasiske BL, O'Donnell MP, Schmitz PG et al. (1990) Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37: 880–891 CASPubMed Google Scholar
Kasiske BL, O'Donnell MP, Clearly MP, Keane WF (1988) Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33: 667–672 CASPubMed Google Scholar
Hostetter TT, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380 ArticleCASPubMed Google Scholar
Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA (1983) Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32: 943–949 ArticleCASPubMed Google Scholar
Zatz R, Prado EBA, Prado MJBA (1989) Aging analbuminemic rats fail to develop focal glomerular sclerosis. Kidney Int 35: 442 Google Scholar
Sasaki T, Kuratya H, Nomura K, Utsunomiya K, Ikeda Y (1990) Amelioration of proteinuria with Pravastatin in hypercholesterolemic patients with diabetes mellitus. Jpn J Med 29: 156–163 CASPubMed Google Scholar
Deslypere JP, Delanghe J, Vermeulen A (1990) Proteinuria as complication of simvastatin treatment. Lancet 336: 1045–1046 Article Google Scholar
Parving H-H, Kastrup J, Smidt UM, Andersen AR, Feldt-Rasmussen B, Sandahl Christiansen J (1984) Impaired autoregulation of glomerular filtration rate in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27: 547–542 ArticleCASPubMed Google Scholar
Hommel E, Mathiesen E, Edsberg B, Bahnsen M, Parving H-H (1986) Acute reduction of arterial blood pressure reduces urinary albumin excretion in Type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia 29: 211–215 ArticleCASPubMed Google Scholar
Wiseman MJ, Bognetti ZE, Dodds R, Keen H, Viberti GC (1987) Changes in renal function in response to protein restricted diet in Type 1 (insulin-dependent) diabetic patients. Diabetologia 30: 154–159 ArticleCASPubMed Google Scholar
Hommel E, Mathiesen E, Arnold-Larsen S, Edsberg B, Olsen UB, Parving H-H (1987) Effects of indomethacin on kidney function in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 30: 78–81 CASPubMed Google Scholar
Mathiesen ER, Hommel E, Olsen UB, Parving H-H (1988) Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient nephropathy. Diab Med 5: 145–149 CAS Google Scholar
Garg A, Grundy SM (1988) Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. N Engl J Med 318: 81–86 CASPubMed Google Scholar